HALOZYME THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Halozyme Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Halozyme Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $34.8M, a 9.66% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $34.8M -$3.72M -9.66% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $36.2M -$3.24M -8.21% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $36.8M -$3.63M -8.98% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $37.2M +$31.6M +564% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $38.5M +$32.8M +573% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $39.4M +$37.9M +2411% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $40.5M +$38.5M +1920% Dec 31, 2022 10-K 2024-02-20
Q3 2022 $5.61M +$3.18M +131% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $5.72M +$2.89M +102% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $1.57M -$1.53M -49.3% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $2M -$1.3M -39.3% Dec 31, 2021 10-K 2023-02-21
Q3 2021 $2.43M -$1.25M -34% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $2.84M -$1.72M -37.7% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $3.1M -$1.88M -37.7% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $3.3M -$549K -14.3% Dec 31, 2020 10-K 2022-02-22
Q3 2020 $3.68M -$3.11M -45.8% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $4.55M -$1.96M -30.1% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $4.97M -$1.97M -28.4% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $3.85M +$3.85M Dec 31, 2019 10-K 2021-02-23
Q3 2019 $6.78M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $6.51M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $6.94M Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $0 Dec 31, 2018 10-K 2020-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.